Position in CRMD
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$69,638
+$64,254 QoQ
Shares Held
10,256
+2115.1% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUMMIT SECURITIES GROUP LLC holds $1,851,878 across 25 Biotechnology names. CRMD ranks #4 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
23,000 | $1,212,560 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
138 | $106,624 | |
| 3 | MRNA |
Moderna, Inc.
|
1,626 | $82,600 | |
| 4 | CRMD |
CorMedix Inc.
This page
|
10,256 | $69,638 | |
| 5 | FULC |
Fulcrum Therapeutics, Inc.
|
6,975 | $53,498 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
1,197 | $46,072 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
460 | $42,494 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
400 | $38,900 |
All Filings in CRMD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $69,638 | 10,256 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $5,384 | 463 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $31,921 | 2,591 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||